5th International Congress on Maternal Hemodynamics 2024

Description Include: 8 videos, size: 12.6 GB Target Audience: obstetricians, cardiovascular physicians Sample video: contact me for sample video Information: The International Working Group on Maternal Hemodynamics is glad to announce the upcoming Fifth International Congress on Maternal Hemodynamics, which will be held in Florence 7-9 March 2024. Free communications will be presented in the plenary sessions together with lectures from international experts in the field. We have allowed time to encourage interaction and discussion of all of these presentations. Abstracts will be published on the Italian Journal of Gynaecology and Obstetrics. The congress will be an opportunity to share the latest research in the field of cardiovascular system before, during and after pregnancy. The main sessions that will be treated during the congress. Methodology for the detection of maternal hemodynamics; long term cardiovascular consequences of maternal fetal complications in preg-nancy; hemodynamics in fetal growth restriction, twin pregnancy/IVF, hypertensive disorders of pregnancy and preeclampsia, labour, and diabetes; obstetric anesthesia and maternal hemodynamics; hemodynamics as an help for medical treatment in hypertensive disease. The International Working Group on Maternal Hemodynamics is an international association of Obstetricians, Cardiovascular Physicians and researchers from all over the world interested in the cardiovascular system adaptation during pregnancy and its relation to maternal and fetal outcome. The 5th International Congress on Maternal Hemodynamics 2024 is designed for a diverse group of professionals interested in the cardiovascular system’s adaptation during pregnancy and its impact on maternal and fetal outcomes. The target audience includes: Obstetricians Cardiovascular physicians Researchers Healthcare professionals involved in maternal and fetal care This congress provides an opportunity to share the latest research and advancements in maternal hemodynamics, fostering interaction and discussion among experts in the field.   Topics: *Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below SESSION 1 – Methodology how to collect data in a proper way.mp4 SESSION 2 – Long term consequences andSESSION 3 – Hemodynamics in Fetal Growth restriction.mp4 SESSION 4 – Basic research.mp4 SESSION 5 – Labor.mp4 SESSION 6 – Obstetric Anesthesia and SESSION 7 – Diabetes in Pregnancy.mp4 SESSION 8 – Medical treatment in hypertensive disease let’s have some help from hemodynamics.mp4 SESSION 9 – Twin pregnancy IVF.mp4 SESSION 10 – HDP-Preeclampsia.mp4   * Detail: Thursday, March 7th 14:00-14:10 Welcome Prof. F. Mecacci; Prof. H. Valensise 14:10-15:00 SESSION 1 – Methodology: how to collect data in a proper way Chairman W. Gyselaers (I. Wilkinson) 14:10-14:30 Blood pressure measurement and/or hemodynamics assessment: what should we do? W. Gyselaers 14:30-14:50 The role of POCUS in Maternal Medicine J. Cornette 14:50-15:10 The Femtech Revolution-Reshaping and digitalizing women’s-Improving Global Maternal Offspring Outcome M. Hod 15:10-15:20 Discussion 15:20-15:40 The modern maternal hemodynamic features for prediction of preeclampsia Dmytro Konkov Plasma renin concentration throughout healthy and hypertensive pregnancy: a systematic review and meta-analysis Maaike van Ochten On the pathogenesis of preeclampsia: a new pre-pregnancy risk factor for preterm and term preeclampsia and evidence from recurrences supporting their common origin. Svitlana Arbuzova 15:40-16:00 Coffee break 16:00-17:30 SESSION 2 – Long term consequences Chairman: B. Thilaganathan- C. Ghossein-Doha 16:00-16:20 Optimising maternal cardiovascular health outcomes in preeclampsia B. Thilaganathan 16:20-16:40 Diversity in CV Medicine, beyond the gender perspective C. Ghossein-Doha 16:40-17:00 Pre-eclampsia and long term cardiovascular morbidity: cause or association? C. McEniery 17:00-17:10 Discussion 17:10-17:35 Early third trimester maternal cardiac morphometry in high-risk pregnancies of placental insufficiency Judit Martinez-Egea First trimester maternal hemodynamics in patients with or without chornic hypertension Hyunyoung Ahn Associations Between Blood Pressure Variability and Perinatal Outcomes Natalia Boscaneanu 17:35-18:40 SESSION 3 – Hemodynamics in Fetal Growth restriction Chairman: J. Cornette- H.Valensise 17:35-17:55 Preclinical hemodynamic profile in early and late FGR B. Vasapollo 17:55-18:15 Modelling for prediction of outcome in Late FGR R. Napolitano 18:15-18:25 Discussion 18:25-18:55 Postpartum maternal cardiac adaptation in SGA pregnancies and its correlation with biomarkers of cardiovascular risk Eva Meler Use of Antihypertensive Medications at Discharge and in the Immediate Postpartum Period: Observations from a Cohort of Hypertensive Pregnant Patients at a Canadian Tertiary Centre Kelsey McLaughlin Baroreceptor mediated blood pressure control in women with a history of preeclampsia Nadine Boutkan Friday, March 8th 08:30-10:00 SESSION 4 – Basic research Chairman: T. Mousa-C. McEniery 08:30-08:50 Oxygen and glucose supply in human fetal growth restriction I. Cetin 08:50-09:10 Umbilical Venous flow and maternal hemodynamics D. Farsetti 09:10-09:30 New predictors for hypertensive disorders of pregnancy D.D. Di Martino 09:30-09:50 Does a mother’s heart know? E. J Stohr 09:50-10:00 Discussion 10:00-10:30 The impact of obesity on maternal hemodynamics… Pouya Abhari Evaluating Trajectories of Placental Growth Factor (PlGF) and Pregnancy Outcomes Following Multimodal Screening for Preeclampsia. John Snelgrove Study protocol for the randomized controlled TREASURE trial: timely recovery after subclinical heart failure Zenab Mohseni-Alsalhi Early-life consequences of Hypertensive Disorders during Pregnancy: an exploration of the retinal microvasculature in young children. Hanne Sleurs 10:30-11:00 Coffee Break 11:00-12:30 SESSION 5 – Labor Chairman: H. Valensise 11:00-11:20 Fetal cardiac function in active labor T. Ghi 11:20-11:40 Maternal hemodynamics during labor with epidural anesthesia S. Giannubilo 11:40-12:00 Maternal hemodynamics in the delivery room A. Dall’Asta 12:00-12:20 Fetal cardiac function: new tools T. Stampalja 12:20-12:30 Discussion 12:30-13:00 Association between nadverse neonatal outocom and maternal haemodynamics Christoph Lees Preconception physical activity alters the cardiovascular profile of women at risk for gestational hypertensive disorders in a profile-specific way. Pauline Dreesen Arterial stiffness and endothelial function after preeclampsia: can they predict the outcome of the subsequent pregnancy? Ellen Faes Non-invasive maternal hemodynamics for the classification of pregnancies complicated by fetal growth restriction Andrea Caricati 13:00-14:00 Light Lunch 14:00-15:50 SESSION 6 – Obstetric Anesthesia Chairman: M. Micaglio, G.P. Novelli 14:00-14:20 Hemodynamic impact of neuraxial anesthesia for CS M. Van de Velde (online) 14:20-14:40 Maternal Hemodynamic changes in pregnancy: what’s new? L. Lorini 14:40-15:00 Update on fluid management in the pregnant patient L. Frassanito 15:00-15:20 Homeostasis and noninvasive macrocirculation evaluation in pregnant patient M. Micaglio 15:20-15:40 Cardiac output-guided maternal positioning might improve pregnancy outcomes T. Archer 15:40-15:50 Discussion 15:50-17:00 SESSION 7 – Diabetes in Pregnancy Chairman: F. Mecacci; Michael Paidas 15:50-16:10 Phenotipic eterogeneity of GDM: what is the relationship with the cardiovascular function F. Mecacci 16:10-16:30 Routine mid gestation oral glucose tolerance test ‘plus’ to predict later preeclampsia M. Spanderman 16:30-16:50 Changes in arterial stiffness among women with gestational diabetes T. Mousa 16:50-17:00 Discussion 17:00-17:30 Coffee Break 17:30-19:00 SESSION 8 – Medical treatment in hypertensive disease: let’s have some help from hemodynamics Chairman: M. Spanderman 17:30-17:50 Why management of PE must be tailored C. Lees 17:50-18:10 Hypodynamic hypertension in pregnancy: update on treatment. G.P Novelli 18:10-18:20 Why understanding pharmocokientics of anti hypertensive medications is important I. Wilkinson 18:20-18:40 The potential of Pentaerytrithyltetranitrate PETN in pregnancies complicated by impaired placental perfusion and maternal hemodynamics T. Groten 18:40-19:00 Maternal hemodynamics in GUCH pregnancies F. Prefumo 19:00-19:10 Discussion Saturday, March 9th 08:30-09:40 SESSION 9 – Twin pregnancy/IVF Chairman: A. Khalil; F. Mecacci 08:30-08:50 Screening for preeclampsia in twin pregnancies D. Schlembach 08:50-09:10 Hemodynamic and cardiac changes during twin vs singleton pregnancy R. Orabona 09:10-09:30 Preeclampsia in twins how different from singletons A. Khalil (online) 09:30-09:40 Discussion 09:40-10:20 Circulating Angiogenic Factors levels in women with Hypertensive Disorders of Pregnancy (HPD) according to the baseline hemodynamic findings Beatrice Valentini The correlation between first-trimester serum biochemical and biophysical markers and skin microvascular reactivity assessed by laser speckle contrast imaging Mor Huri Maternal and fetal hemodynamics assessment to predict IUGR in twin Pregnancies Benedetta Lupoli Small-for-gestational-Age Fetuses characteristics and outcome in pregnancies complicated by gestational diabetes Sara Nardini (recorded) Association between adverse neonatal outcome and maternal haemodynamics and biomarkers in SGA and FGR Bronacha Mylrea-Foley Physical activity during pregnancy: maternal hemodynamics and obstetrics outcomes Anna Luna Tramontano 10:20-10:50 Coffee Break 10:50-11:20 The role of umbilical vein blood flow assessment in the prediction of fetal growth: a prospective observational cohort study Daniele Farsetti Haemodynamic evaluation in pregnancies complicated by T1DM (Type 1 Diabetes Mellitus): differences in LGA (Large for Gestational Age) vs AGA (Appropriate for Gestational Age) newborns Benedetta Baggio Maternal hemodynamics in placental implantation abnormalities: a pilot study Filomena Maellaro Hemodynamic and impedenzometric profile in low-risk pregnant women at term with excessive gestational weight gain. A pilot study Teresa Aiolfi 11:20-12:30 SESSION 10 – HDP-Preeclampsia Chairman: C. Lees- E. Ferrazzi 11:20-11:40 Do all women after HDP have the same long-term risk of CVD in later life? J.J. Duvekot 11:40-12:00 Cardiovascular adaptations in Preeclampsia M. Charakida 12:00-12:20 Discussion 12:20 Prize for the best oral presentation Closing remarks